Adaptive Biotechnologies Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: June 3rd, 2021
Here are a few of the most interesting Adaptive Biotechnologies statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Adaptive Biotechnologies Facts
- Website: Official Website
- Year Founded: 2009
- Headquarters: Seattle, WA
- Founder(s): Chad Robins, Christopher Carlson, Harlan Robins
- Current Chief Executive: Chad Robins
What is Adaptive Biotechnologies?
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases — such as cancer, autoimmune conditions, and infectious diseases — are diagnosed and treated. (source)
Adaptive Biotechnologies Employee Count
Number of Adaptive Biotechnologies employees:
Last updated 1/1/20
Adaptive Biotechnologies Revenue Totals
Adaptive Biotechnologies annual revenue:
- 2019: $85.071 million
- 2018: $55.663 million
- 2017: $38.448 million
Adaptive Biotechnologies annual net loss:
- 2019: $68.606 million
- 2018: $46.447 million
- 2017: $42.831 million
Please note that some of these numbers are easier to find than others. A few of these Adaptive Biotechnologies stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.